奥美拉唑治疗消化性溃疡伴发慢性胃炎的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Omeprazole in the treatment of peptic ulcer with chronic gastritis.Methods A total of 200 patients with peptic ulcer associated with chronic gastritis in our hospital from October 2017 to October 2019 were selected.They were divided into two groups by random number table method,and all patients were given basic medicationand,the control group was treated with Ranitidine,the observation group was treated with Omeprazole.The clinical symptoms recovery time,adverse reaction,total treatment efficiency and ulcer healing rate were compared between the two groups.Results After treatment,the recovery time of abdominal pain,belching,acid reflux,nemia,nausea and vomiting in the observation group was shorter than that in the control group; the total incidence rate of adverse reactions in the observation group was lower than that in the control group; the total efficiency of the observation group was 98.00%,higher than that in the control group of 77.00%,the ulcer healing rate of the observation group was 82.00%,which was higher than that of the control group of 62.00%,the differences were statistically significant (P＜0.05).Conclusion The use of Omeprazole in patients with peptic ulcer accompanied by chronic gastritis can effectively shorten the recovery time of clinical symptoms,reduce the rate of adverse reactions,and improve the treatment efficiency and ulcer healing rate.It has achieved good clinical results and is suitable for clinical use.

Key words： Peptic ulcer with chronic gastritis Omeprazole Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIANG He
	HE Jin-yun

Cite this article:

LIANG He,HE Jin-yun. Clinical effect of Omeprazole in the treatment of peptic ulcer accompanied by chronic gastritis[J]. 中国当代医药, 2020, 27(31): 56-58.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I31/56

[1]	石振东，赵凤娥，陈莫耶.艾普拉唑与奥美拉唑治疗幽门螺杆菌相关十二指肠溃疡的疗效比较[J].中国医院用药评价与分析，2019，19（12）：1485-1487.
[2]	张晓敏.用泮托拉唑与奥美拉唑对服用非甾体类抗炎药导致消化性溃疡出血的老年患者进行治疗的效果对比[J].当代医药论丛，2019，17（21）：151-153.
[3]	申明，张铭光，王瑞，等.血凝酶联合奥美拉唑钠治疗消化性溃疡对患者胃酸分泌功能及血清EGF VEGF SOD 水平的影响[J].河北医学，2019，25（12）：1941-1945.
[4]	段红妮.艾司奥美拉唑或奥美拉唑为主的三联法治疗Hp阳性消化性溃疡的有效性和安全性比较[J].临床医学研究与实践，2019，4（25）：51-52.
[5]	廖勤贵.奥美拉唑镁肠溶片与注射用奥美拉唑钠治疗消化性溃疡出血疗效与安全性的比较研究[J].临床合理用药杂志，2019，12（21）：73-75.
[6]	余报，高艳玲，何艳，等.奥美拉唑联合血凝酶及奥曲肽治疗老年消化性溃疡伴出血的临床观察[J].临床合理用药杂志，2019，12（25）：63-64.
[7]	于庆祥.康复新液、凝血酶冻干粉与奥美拉唑联用方案治疗消化性溃疡出血的临床效果评价[J].中国医药指南，2019，17（22）：178-179.
[8]	李竹林，李继昌.以兰索拉唑或奥美拉唑为主的三联疗法治疗幽门螺杆菌阳性消化性溃疡的效果比较[J].临床医学研究与实践，2019，4（11）：36-37.
[9]	方之洪，刘春，周慧，等.艾司奥美拉唑为主的四联疗法治疗幽门螺杆菌阳性儿童消化性溃疡的疗效分析[J].现代消化及介入诊疗，2018，23（6）：753-755.
[10]	李彬龙，和水祥，李颜霞.两种方案根除消化性溃疡和慢性胃炎患者幽门螺杆菌的疗效对比[J].西部医学，2019，31（7）：1053-1056.
[11]	黄敏霞.奥美拉唑联合凝血酶治疗慢性胃炎合并消化性溃疡出血患者的临床效果观察[J].临床合理用药杂志，2018，11（29）：43-44.
[12]	张桥东，曾燕文，张华东，等.奥美拉唑治疗消化性溃疡伴发慢性胃炎的效果分析[J].青岛医药卫生，2018，50（1）：37-39.
[13]	宋佳，孙海丰.雷贝拉唑四联序贯疗法对于消化性溃疡合并慢性胃炎患者的疗效分析[J].系统医学，2018，3（20）：64-66.
[14]	李霞.布拉酵母菌散联合艾司奥美拉唑四环素呋喃唑酮四联疗法对首次幽门螺杆菌治疗失败的疗效观察[J].中国药物与临床，2019，19（3）：408-410.
[15]	陈敬松，田华，曾秋红，等.慢性胃炎及溃疡合并幽门螺杆菌感染患者采用四联药物根治性治疗后辅助铋剂模拟剂治疗的效果[J].临床医学工程，2017，24（7）：981-982.